Drugs / EC0225
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00441870 | Feb 2007 → Nov 2010 | cancer | Endocyte | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC0225 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00441870 ↗ |
| Route | Intravenous | “administered by intravenous bolus (IV)” NCT00441870 ↗ |